Context Compared to the relatively benign effects of increased subcutaneous adipose tissue (SAT), increased visceral adipose tissue (VAT) volume is a causal risk factor for hypertension, hyperlipidaemia, type 2 diabetes and cardiovascular disease. In rodents, increased VAT volume and triglyceride density and ectopic lipid accumulation in kidneys and liver have been induced by alterations in the gut microbiome. However, few studies have characterized these relationships in humans. Objective To evaluate the tissue triglyceride content of VAT and SAT, liver, kidneys and pancreas in male and female adults and assess associations with markers of glucose tolerance, serum insulin and lipids and characteristics of the gut microbiome. Design Cross-sectional observational Setting Clinical Research Centre Participants Healthy human adults (n = 60) Methods BMI, body composition, and oral glucose tolerance were assessed. Microbiome analysis was conducted on stool samples using 16S rRNA v3 amplicon sequencing. The triglyceride content of VAT, SAT, liver, kidney and pancreas were determined by assessing proton density fat fraction (PDFF) with magnetic resonance imaging (MRI). Results Higher VAT PDFF and the ratio of VAT-to-SAT PDFF were related to higher BMI, HbA1c, HOMA-IR, non-HDL cholesterol, plasma triglycerides, LDL cholesterol and lower HDL cholesterol. A higher VAT PDFF and VAT-to-SAT PDFF ratio were associated with lower alpha diversity and altered beta diversity of the gut microbiome. Differences in VAT were associated with higher relative abundance of the phylum Firmicutes, lower relative abundance of the phylum Bacteroidetes, and enrichment of the bacterial genera Dorea, Streptococcus, and Solobacterium. Conclusions VAT PDFF measured with MRI is related to impaired glucose homeostasis, dyslipidemia and differences in the gut microbiome, independently of the total body fat percentage.